tiprankstipranks
Sunshine Biopharma (SBFM)
NASDAQ:SBFM
US Market
SBFM
Sunshine Biopharma
RESEARCH TOOLSreports

Sunshine Biopharma (SBFM) Income Statement

426 Followers

Sunshine Biopharma Income Statement

Last quarter (Q4 2025), Sunshine Biopharma's total revenue was $8.58M, a decrease of -10.60% from the same quarter last year. In Q4, Sunshine Biopharma's net income was $-2.14M. See Sunshine Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Mar 23Dec 21
Total Revenue
$ 36.31M$ 34.87M$ 24.09M$ 4.35M$ 228.43K
Gross Profit
$ 11.92M$ 10.67M$ 8.34M$ 1.70M$ 110.60K
Operating Expenses
$ 16.40M$ 16.48M$ 13.12M$ 10.37M$ 2.55M
Depreciation and Amortization
$ 332.07K$ 223.53K$ 149.15K$ 25.16K$ 12.74K
EBITDA
$ -4.15M$ -5.14M$ -3.82M$ -26.45M$ -12.09M
Operating Income
$ -4.48M$ -5.81M$ -4.79M$ -8.67M$ -2.44M
Other Income/Expenses
$ -1.47M$ 443.15K$ 674.42K$ -17.84M$ -10.00M
Pretax Income
$ -5.95M$ -5.37M$ -4.11M$ -26.51M$ -12.44M
Net Income
$ -5.98M$ -5.13M$ -4.51M$ -26.74M$ -12.44M
Per Share Metrics
Basic EPS
$ -1.44$ -7.32$ -351.36$ -3.52K$ -9.77K
Diluted EPS
$ -1.44$ -7.32$ -351.36$ -3.52K$ -9.52K
Weighted Average Shares Outstanding
 4.16M 701.75K 12.16K 7.59K 1.31K
Weighted Average Shares Outstanding (Diluted)
 4.16M 701.75K 12.16K 7.59K 1.31K
Currency in USD

Sunshine Biopharma Earnings and Revenue History